
Pen kit box
From $138.40
- What you get
- The reusable pen, 1 dual-chamber vial, 12 needles and a booklet, in the VETUD box
- BAC water
- Included, in the cartridge

3 / 5
VTD-SM1 · Weight management
Long-acting copy of the gut hormone GLP-1, studied in weight and diabetes research.
$138.40
Regular price $173.00
20% offPen kit box · 10 mg
Free standard shipping on orders over $200
Choose a format
Amount
In the box · Pen kit box
VETUD box with the reusable pen body, 1 dual-chamber vial (lyophilized peptide in one chamber, bacteriostatic water in the other), 12 disposable needles and an instruction booklet
All Products listed on this site are for research purposes only. All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion.
A copy of a gut hormone that makes you feel full. One of the most studied weight-loss medicines in the world.
Approved in the US, EU and many other countries. Ozempic and Rybelsus treat type 2 diabetes; Wegovy is for weight management. A daily Wegovy pill was approved in the US in December 2025.
Step 1 of 5: Cells
Step 2 of 5: Animals
Step 3 of 5: Small human studies
Step 4 of 5: Large trials
Step 5 of 5: Approved medicine
Semaglutide is a man-made version of GLP-1, a hormone your gut releases after you eat. The natural hormone is broken down within minutes. Semaglutide was changed slightly so it lasts about a week, which is why the injection is given once a week.
GLP-1 tells your brain you’re full, slows down how fast your stomach empties, and helps your body release insulin when blood sugar rises. Semaglutide does the same, for much longer.
These results come from published studies of Semaglutide, not from this research material.
STEP 1 trial · 1,961 adults with obesity or overweight, compared with a placebo (a dummy injection)
Semaglutide
Placebo
Source: Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) · Wilding et al. · New England Journal of Medicine · 2021
SELECT trial · 17,604 adults with heart disease and overweight
Semaglutide
Placebo
A 20% lower risk of these events than on placebo.
Source: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) · Lincoff et al. · New England Journal of Medicine · 2023
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) ↗
Wilding et al. · New England Journal of Medicine · 2021
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) ↗
Lincoff et al. · New England Journal of Medicine · 2023
Discovery of the Once-Weekly GLP-1 Analogue Semaglutide ↗
Lau et al. · Journal of Medicinal Chemistry · 2015
Scientific background concerns the named molecule. Batch composition and analytical results must be established from the product documentation. All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion.
SKUVTD-SM1-VIAL-10MG, VTD-SM1-VIAL-20MG, VTD-SM1-PEN-10MG, VTD-SM1-BOX-10MG, VTD-SM1-PEN-20MG, VTD-SM1-VIAL-40MG, VTD-SM1-BOX-20MG, VTD-SM1-PEN-40MG, VTD-SM1-BOX-40MG
Follow the manufacturer's batch-specific storage temperature and conditions.
Keep in original packaging, away from direct sunlight and excess heat.
Refer to the lot-specific expiry date and stability documentation. Shelf life should not be inferred from the product name alone.
For solvent compatibility or preparation specifications, request the manufacturer’s batch documentation. Research protocols should be established by qualified laboratory personnel.
Every product comes three ways. It's the same peptide and the same amounts; what changes is the packaging, what's included and the price. Start with the pen kit box, which has the reusable pen, then refill it with dual-chamber vials.

From $138.40

From $106.40

From $50.40
The freeze-dried peptide and the bacteriostatic (BAC) water sit in separate chambers, divided by a rubber stopper. They stay apart until the cartridge is used.
The pen kit box has the reusable pen body with a dual-chamber vial, 12 disposable needles and a booklet. The drive, dial and indicator window stay with the pen: when a cartridge is empty, fit a new dual-chamber vial.
Choose the vial if you already have bacteriostatic water and your own lab supplies. It's the lowest price for the same amount.
Related


Small-molecule NNMT inhibitor studied in cell metabolism research.
Pen kit box / Dual-chamber vial / Vial · 10 mg / 50 mg
From$48.00regular price $60.00
AvailableAll Products listed on this site are for research purposes only


Fragment of human growth hormone studied in fat-metabolism research.
Pen kit box / Dual-chamber vial / Vial · 5 mg / 10 mg
From$33.60regular price $42.00
AvailableAll Products listed on this site are for research purposes only


Triple GIP, GLP-1 and glucagon receptor agonist in clinical metabolic research.
Pen kit box / Dual-chamber vial / Vial · 10 mg / 20 mg / 40 mg
From$61.60regular price $77.00
AvailableAll Products listed on this site are for research purposes only
Education
Plain-language guides, news about new studies and selected videos from doctors and researchers. Published studies are about the named compound; they don't establish the safety or performance of this research product.

Weight management
Ozempic, Wegovy, Rybelsus
A copy of a gut hormone that makes you feel full. One of the most studied weight-loss medicines in the world.

StudyWeight management
A small MRI analysis found a 12% reduction in visceral-fat volume, not body weight. A possible effect on weight regain after GLP-1 medicines is still an animal finding.

StudyWeight management
New phase 3 results show strong weight loss in people with type 2 diabetes or heart disease. Lilly plans to apply for US approval by early 2027.

StudyWeight management
Eli Lilly’s experimental “triple” hormone medicine helped people lose more than a quarter of their body weight on the top dose.
Ohio State Wexner Medical Center
How the brand names relate to semaglutide and tirzepatide and their prescribed uses. Older recordings may not cover later indications or formulations.
Allison L. Rhodes, MD · obesity medicine
Discusses the compound
Discusses Semaglutide or its clinical context. Read the original studies linked here for the exact formulation, population and outcomes.
Nick Norwitz
How GLP-1 medicines work in the gut and brain, in clear language.
Nick Norwitz, MD, PhD
Discusses the compound
Discusses Semaglutide or its clinical context. Read the original studies linked here for the exact formulation, population and outcomes.
Ohio State Wexner Medical Center
A hospital explainer of GLP-1 signalling, appetite and blood-sugar regulation.
Allison L. Rhodes, MD · obesity medicine
Related biology
Background on GLP-1 signalling for understanding Semaglutide. It does not demonstrate benefits of this compound or formulation.